[Use of iumeks in the combined therapy of parkinsonism patients ].
D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006613:Higher Nervous Activity / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D012642:Selegiline
Primenenie iumeksa v kompleksnoĭ terapii bol'nykh parkinsonizmom.